| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 77,4 k € | +32.1% | 58,6 k € | -49.7% | 116,5 k € | -27.1% | 159,8 k € | +16.7% | 137,0 k € | +9.5% | 125,1 k € | +13.1% | 110,7 k € | -30.2% | 158,6 k € | -14.1% | 184,6 k € | +11.9% | 165,0 k € | +19.3% | 138,3 k € | -0.8% | 139,4 k € | +47.1% | 94,8 k € | -14.7% | 111,1 k € | +26.2% | 88,1 k € | -7.5% | 95,2 k € | -6.2% | 101,5 k € | +16.7% | 87,0 k € | +20.8% | 72,0 k € | |
| EBITDA | -63,9 k € | -395.8% | 21,6 k € | -79.5% | 105,5 k € | -32.5% | 156,3 k € | +19.1% | 131,2 k € | +23.7% | 106,1 k € | -1.6% | 107,8 k € | -27.8% | 149,3 k € | -14.7% | 175,0 k € | +18.6% | 147,6 k € | +16.2% | 127,0 k € | -1.2% | 128,5 k € | +48.3% | 86,6 k € | -21.8% | 110,8 k € | +26.3% | 87,7 k € | -7.4% | 94,8 k € | -6.3% | 101,2 k € | +16.7% | 86,7 k € | +20.9% | 71,7 k € | |
| Operating profit | -82,6 k € | -1303.1% | 6,9 k € | -90.2% | 69,7 k € | -42.2% | 120,6 k € | +26.3% | 95,5 k € | +35.1% | 70,7 k € | -0.5% | 71,1 k € | -28.8% | 99,9 k € | -21.6% | 127,4 k € | +21.5% | 104,8 k € | +12.7% | 92,9 k € | -9.1% | 102,3 k € | +19.2% | 85,8 k € | -21.5% | 109,3 k € | +25.3% | 87,3 k € | -7.1% | 93,9 k € | -6.6% | 100,6 k € | +16.7% | 86,2 k € | +21.1% | 71,2 k € | |
| Profit/loss | -84,1 k € | -3192.3% | -2,6 k € | -105.4% | 47,6 k € | +58.7% | 30,0 k € | -45.7% | 55,3 k € | +57.8% | 35,0 k € | -9.6% | 38,7 k € | -25.7% | 52,1 k € | -27.4% | 71,7 k € | +22.7% | 58,5 k € | +71.2% | 34,2 k € | +34.1% | 25,5 k € | -48.6% | 49,6 k € | -46.0% | 91,9 k € | +64.0% | 56,0 k € | -17.9% | 68,2 k € | -7.9% | 74,0 k € | +34.3% | 55,1 k € | +33.0% | 41,4 k € | |
| Equity | 660,4 k € | -15.2% | 778,7 k € | -0.3% | 781,3 k € | +6.3% | 734,7 k € | +4.3% | 704,7 k € | +3.0% | 684,5 k € | +5.4% | 649,5 k € | +6.3% | 610,7 k € | +3.8% | 588,6 k € | +13.9% | 516,9 k € | +8.0% | 478,4 k € | +206.2% | 156,3 k € | -66.9% | 472,1 k € | +2.2% | 462,1 k € | +14.5% | 403,5 k € | +9.8% | 367,5 k € | +17.6% | 312,6 k € | +31.0% | 238,6 k € | +40.2% | 170,1 k € | |
| Total assets | 705,0 k € | -10.5% | 787,4 k € | -32.5% | 1,2 M € | -0.4% | 1,2 M € | +0.0% | 1,2 M € | -3.4% | 1,2 M € | -1.8% | 1,2 M € | -0.7% | 1,2 M € | -4.3% | 1,3 M € | +16.0% | 1,1 M € | +3.0% | 1,1 M € | -1.2% | 1,1 M € | +108.3% | 527,7 k € | +6.7% | 494,8 k € | +21.9% | 405,8 k € | +9.4% | 371,1 k € | +17.7% | 315,4 k € | +30.6% | 241,5 k € | +27.0% | 190,1 k € | |
| Cash | 68,3 k € | +96.3% | 34,8 k € | -52.4% | 73,0 k € | +5.0% | 69,5 k € | +9.4% | 63,6 k € | +2.2% | 62,2 k € | -4.9% | 65,4 k € | -10.2% | 72,8 k € | +12.9% | 64,5 k € | +87.9% | 34,3 k € | +103.9% | 16,8 k € | +24.2% | 13,6 k € | -66.5% | 40,5 k € | +101.9% | 20,1 k € | +467.3% | 3,5 k € | -77.7% | 15,9 k € | -25.6% | 21,3 k € | +32.6% | 16,1 k € | -33.8% | 24,3 k € | |
| Debts | 44,5 k € | +414.3% | 8,7 k € | -97.7% | 384,5 k € | -11.7% | 435,7 k € | -6.4% | 465,7 k € | -11.6% | 526,8 k € | -9.8% | 584,2 k € | -7.4% | 631,1 k € | -10.9% | 708,4 k € | +17.7% | 601,7 k € | -1.0% | 607,8 k € | -35.5% | 943,0 k € | +1597.0% | 55,6 k € | +69.9% | 32,7 k € | +1337.0% | 2,3 k € | -36.3% | 3,6 k € | +30.8% | 2,7 k € | -6.9% | 2,9 k € | -85.3% | 20,0 k € | |
Private limited company · Mons · incorporated on 17/12/1999
Private limited company loss-making in the latest fiscal year. Cash position rising (+96.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
FERLIMMO is a Private limited company incorporated in 1999. Its main activity is: Specialist medical practice activities. Its registered office is in Mons.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette